atcc deposit designation pta 10664 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
97
Structured Review
ATCC
atcc deposit designation pta 10664
Atcc Deposit Designation Pta 10664, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 6536 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atcc+deposit+designation+pta+10664/Hybridoma+murine+cells+3C6%2E4%2E2/us12559566-373-22-22
Average 97 stars, based on 6536 article reviews
Atcc Deposit Designation Pta 10664, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 6536 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atcc+deposit+designation+pta+10664/Hybridoma+murine+cells+3C6%2E4%2E2/us12559566-373-22-22
Average 97 stars, based on 6536 article reviews
atcc deposit designation pta 10664 - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Binding Assay:Article Title: CD37-binding molecules immunoconjugates thereof Article Snippet: .. In certain embodiments, the antibody or antigen binding fragment thereof is produced by hybridoma selected from the group consisting of Article Title: CD37-binding molecules and immunoconjugates thereof Article Snippet: .. In certain embodiments, the antibody or antigen binding fragment thereof is produced by hybridoma selected from the group consisting of Produced:Article Title: CD37-binding molecules immunoconjugates thereof Article Snippet: .. In certain embodiments, the antibody or antigen binding fragment thereof is produced by hybridoma selected from the group consisting of Article Title: CD37-binding molecules immunoconjugates thereof Article Snippet: .. In certain embodiments, the CD37 antibody can be the antibody produced from a hybridoma selected from the group consisting of consisting of Article Title: Methods for improving anti-CD37 immunoconjugate therapy Article Snippet: In some instances, the anti-CD37 immunoconjugate comprises an antibody or antigen-binding fragment thereof that contains the same heavy chain and light chain sequences of the antibody produced by the hybridoma of ATCC Deposit Designation PTA-10664 and the cytotoxic agent DM1. .. In some instances, the anti-CD37 immunoconjugate comprises an antibody or antigen-binding fragment thereof that contains the same heavy chain and light chain sequences of the antibody produced by the hybridoma of Article Title: Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Article Snippet: .. In certain embodiments, the CD37 antibody can be the antibody produced from a hybridoma selected from the group consisting of Article Title: Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Article Snippet: In certain embodiments, the antibody or antigen-binding fragment thereof comprises polypeptides differing from SEQ ID NOs:16-18 and 37 and 19-21 by conservative amino acid substitutions only. .. In certain embodiments, the CD37 antibody can be the antibody produced from a hybridoma selected from the group consisting of Article Title: Preparation of maytansinoid antibody conjugates by a one-step process Article Snippet: .. In certain embodiments, the CD37 antibody can be the antibody produced from a hybridoma selected from the group consisting of consisting of Article Title: CD37-binding molecules and immunoconjugates thereof Article Snippet: .. In certain embodiments, the CD37 antibody can be the antibody produced from a hybridoma selected from the group consisting of consisting of Article Title: CD37-binding molecules and immunoconjugates thereof Article Snippet: .. In certain embodiments, the antibody or antigen binding fragment thereof is produced by hybridoma selected from the group consisting of |